Date | Open | Close | Daily High | Daily Low |
---|
Date | Analyst | Rating | Price | |||
---|---|---|---|---|---|---|
06/03/25 | Evercore | Maintained Buy | $190 | |||
05/05/25 | Piper Sandler | Maintained Hold | $164 | |||
04/25/25 | Raymond James Financial, Inc. | Maintained Buy | $185 | |||
04/25/25 | Morgan Stanley | Maintained Buy | $180 | |||
04/25/25 | Citigroup Corp. | Maintained Buy | $181 | |||
04/25/25 | Bank of America Merrill Lynch | Maintained Buy | $180 | |||
04/22/25 | RBC Capital Markets | Maintained Hold | $164 | |||
04/11/25 | J.P. Morgan | Maintained Buy | $172 | |||
03/27/25 | Barclays Capital | Maintained Hold | $165 | |||
02/24/25 | Piper Sandler | Maintained Hold | $172 | |||
01/23/25 | RBC Capital Markets | Maintained Hold | $164 | |||
01/23/25 | Stifel, Nicolaus & Co., Inc. | Maintained Buy | $165 | |||
01/23/25 | Wells Fargo & Co | Maintained Buy | $180 | |||
01/23/25 | Barclays Capital | Maintained Hold | $159 | |||
01/23/25 | D.A. Davidson & Co. | Maintained Buy | $209 | |||
07/24/24 | Jefferies & Company Inc. | Downgraded to Hold | $175 | |||
07/22/24 | J.P. Morgan | Maintained Buy | $181 | |||
07/22/24 | Stifel, Nicolaus & Co., Inc. | Maintained Buy | $161 | |||
07/19/24 | Barclays Capital | Maintained Buy | $174 | |||
07/18/24 | Evercore | Maintained Buy | $183 | |||
07/17/24 | Deutsche Bank | Maintained Buy | $176 | |||
07/10/24 | Citigroup Corp. | Maintained Buy | $190 | |||
06/24/24 | Exane BNP Paribas | Maintained Buy | $187 | |||
04/25/24 | Argus Research Company | Maintained Buy | $185 | |||
04/23/24 | Barclays Capital | Maintained Buy | $170 | |||
04/22/24 | Deutsche Bank | Maintained Buy | $171 | |||
04/22/24 | Jefferies & Company Inc. | Maintained Buy | $182 | |||
04/12/24 | Barclays Capital | Maintained Buy | $168 | |||
04/03/24 | Deutsche Bank | Maintained Buy | $172 | |||
03/01/24 | Goldman Sachs | Maintained Hold | $168 | |||
01/25/24 | Barclays Capital | Maintained Buy | $165 | |||
01/24/24 | RBC Capital Markets | Maintained Hold | $157 | |||
01/24/24 | Stifel, Nicolaus & Co., Inc. | Maintained Buy | $157 | |||
01/24/24 | UBS | Maintained Buy | $178 | |||
01/24/24 | Wells Fargo & Co | Maintained Buy | $170 | |||
01/24/24 | Raymond James Financial, Inc. | Maintained Buy | $175 | |||
01/18/24 | J.P. Morgan | Maintained Buy | $162 | |||
01/16/24 | Barclays Capital | Maintained Buy | $160 | |||
11/13/23 | Jefferies & Company Inc. | Maintained Buy | $177 | |||
10/20/23 | DZ BANK | Upgraded to Buy | $155 | |||
10/19/23 | Wells Fargo & Co | Maintained Buy | $162 | |||
10/19/23 | Stifel, Nicolaus & Co., Inc. | Maintained Buy | $155 | |||
10/16/23 | Stifel, Nicolaus & Co., Inc. | Maintained Buy | $151 | |||
10/12/23 | Barclays Capital | Maintained Buy | $154 | |||
10/12/23 | J.P. Morgan | Maintained Buy | $169 | |||
10/12/23 | Bernstein | Maintained Hold | $153 | |||
09/22/23 | HSBC | Maintained Buy | $179 | |||
09/08/23 | William Blair | Maintained Hold | ||||
08/01/23 | Morgan Stanley | Maintained Buy | $174 | |||
08/01/23 | Bank of America Merrill Lynch | Maintained Buy | $175 |
2025 | 2026 | 2027 | 2028 | |
---|---|---|---|---|
Revenue | 84,217 | 86,599 | 89,772 | 93,777 |
Dividend | 4.01 | 4.20 | 4.38 | 4.16 |
Dividend Yield (in %) | 2.52 % | 2.64 % | 2.76 % | 2.61 % |
EPS | 6.78 | 7.00 | 7.46 | 7.91 |
P/E Ratio | 23.46 | 22.71 | 21.33 | 20.11 |
EBIT | 20,420 | 21,110 | 22,306 | 23,441 |
EBITDA | 23,264 | - | - | 26,725 |
Net Profit | 16,613 | 17,051 | 18,042 | 18,647 |
Net Profit Adjusted | 16,613 | 17,051 | 18,042 | 18,574 |
Pre-Tax Profit | 20,573 | 21,414 | 22,628 | 23,632 |
Pre-Tax Profit Reported | 20,420 | 21,523 | 22,758 | 23,903 |
EPS (Non-GAAP) ex. SOE | 6.78 | 7.00 | 7.46 | 7.91 |
EPS (GAAP) | 6.62 | 6.99 | 7.48 | 8.00 |
Gross Income | 43,182 | 44,264 | 46,267 | - |
Cash Flow from Investing | -3,852 | -3,700 | -3,899 | - |
Cash Flow from Operations | 18,762 | 21,380 | 23,151 | - |
Cash Flow from Financing | -13,473 | -14,824 | -15,862 | - |
Cash Flow per Share | 7.10 | 7.96 | 8.59 | 9.60 |
Free Cash Flow | 15,422 | 16,724 | 17,679 | 18,619 |
Free Cash Flow per Share | 6.16 | 6.95 | 7.34 | - |
Book Value per Share | 22.63 | 23.89 | 24.62 | 23.04 |
Net Debt | 23,687 | 22,243 | 20,380 | 20,163 |
Research & Development Exp. | 2,012 | 2,078 | 2,196 | - |
Capital Expenditure | 3,524 | 3,465 | 3,802 | 3,619 |
Selling, General & Admin. Exp. | 21,334 | 21,631 | 21,470 | - |
Shareholder’s Equity | 54,610 | 57,425 | 57,847 | 55,051 |
Total Assets | 124,208 | 126,701 | 128,876 | - |
Previous Quarter ending 03/31/25 |
Current Quarter ending 06/30/25 |
Next Quarter ending 09/30/25 |
Current Year ending 06/30/25 |
Next Year ending 06/30/26 |
|
---|---|---|---|---|---|
Earnings Estimates | |||||
No. of Analysts | - | 17 | 14 | 22 | 22 |
Average Estimate | - | 1.421 USD | 1.943 USD | 6.781 USD | 7.004 USD |
Year Ago | - | 1.299 USD | 1.650 USD | 6.184 USD | - |
Publish Date | - | 7/29/2025 | 10/15/2025 | - | - |
Revenue Estimates | |||||
No. of Analysts | - | 15 | 11 | 19 | 19 |
Average Estimate | - | 20,796 USD | 22,161 USD | 84,217 USD | 86,599 USD |
Year Ago | - | 20,532 USD | 21,737 USD | 84,039 USD | - |
Publish Date | - | 7/29/2025 | 10/15/2025 | - | - |
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|---|---|
Sales | 84,039.00 | 82,006.00 | 80,187.00 | 76,118.00 | 70,950.00 | 67,684.00 | 66,832.00 |
Change of sales in % | 2.48 | 2.27 | 5.35 | 7.28 | 4.83 | 1.27 | 2.73 |
Gross profit on sales | 43,439.00 | 39,406.00 | 38,212.00 | 39,144.00 | 36,314.00 | 33,437.00 | 33,383.00 |
Gross profit on sales change in % | 10.23 | 3.12 | -2.38 | 7.79 | 8.60 | 0.16 | 0.81 |
Operating income | 20,198.00 | 18,357.00 | 17,913.00 | 18,592.00 | 16,392.00 | 14,512.00 | 14,782.00 |
Operating income change in % | 10.03 | 2.48 | -3.65 | 13.42 | 12.95 | -1.83 | 1.55 |
Income before tax | 18,761.00 | 18,353.00 | 17,995.00 | 17,615.00 | 15,834.00 | 6,069.00 | 13,326.00 |
Income before tax change in % | 2.22 | 1.99 | 2.16 | 11.25 | 160.90 | -54.46 | 0.52 |
Income after tax | 14,879.00 | 14,653.00 | 14,742.00 | 14,306.00 | 13,027.00 | 3,897.00 | 9,750.00 |
Income after tax change in % | 1.54 | -0.60 | 3.05 | 9.82 | 234.28 | -60.03 | -3.55 |
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|---|---|
Total liabilities | 71,811.00 | 73,764.00 | 70,354.00 | 72,653.00 | 73,822.00 | 67,516.00 | 65,427.00 |
Long-term liabilities per share | 16.20 | 16.09 | 15.57 | 16.27 | 16.47 | 14.99 | 14.89 |
Equity | 50,559.00 | 47,065.00 | 46,854.00 | 46,654.00 | 46,878.00 | 47,579.00 | 52,883.00 |
Equity change in % | 7.68 | 0.46 | 0.52 | -0.25 | -1.39 | -9.86 | -5.26 |
Balance sheet total | 122,370.00 | 120,829.00 | 117,208.00 | 119,307.00 | 120,700.00 | 115,095.00 | 118,310.00 |
Balance sheet total change in % | 1.28 | 3.09 | -1.76 | -1.15 | 4.87 | -2.72 | -1.74 |
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|---|---|
Sales per share | 34.00 | 33.02 | 31.58 | 29.26 | 27.02 | 26.65 | 25.16 |
P/E ratio (year end quote, basic EPS) | 27.40 | 25.72 | 24.77 | 24.53 | 24.10 | 76.62 | 21.27 |
P/E ratio (year end quote, diluted EPS) | 27.40 | 25.72 | 24.77 | 24.53 | 24.10 | 76.62 | 21.27 |
Dividend yield in % | 2.32 | 2.43 | 2.45 | 2.40 | 2.53 | 2.64 | 3.57 |
Equity ratio in % | 41.32 | 38.95 | 39.98 | 39.10 | 38.84 | 41.34 | 44.70 |
Debt ratio in % | 58.68 | 61.05 | 60.02 | 60.90 | 61.16 | 58.66 | 55.30 |
Name | Date | shares traded | shares held | Price | type (sell/buy) | option |
---|---|---|---|---|---|---|
McCarthy Christine M | 06/09/2025 | 231.00 | 14,610.83 | n/a | Buy | No |
WOERTZ PATRICIA A | 06/09/2025 | 185.00 | 50,991.97 | n/a | Buy | No |
McEvoy Ashley | 06/09/2025 | 185.00 | 3,636.10 | n/a | Buy | No |
ARNOLD CRAIG | 06/09/2025 | 45.00 | 511.00 | n/a | Buy | No |
Portman Robert Jones | 06/09/2025 | 47.00 | 3,348.75 | n/a | Buy | No |
LUNDGREN TERRY J | 06/09/2025 | 223.00 | 42,893.75 | n/a | Buy | No |
Kempczinski Christopher J | 06/09/2025 | 185.00 | 8,908.66 | n/a | Buy | No |
JIMENEZ JOSEPH | 06/09/2025 | 292.00 | 33,658.41 | n/a | Buy | No |
ARNOLD CRAIG | 06/08/2025 | 466.00 | 466.00 | n/a | Buy | No |
Davis Jennifer L. | 04/28/2025 | 1,000.00 | 51,964.92 | 161.38 | Sell | No |
McEvoy Ashley | 03/10/2025 | 145.00 | 3,433.95 | n/a | Buy | No |
Coombe Gary A | 02/27/2025 | 35,000.00 | 22,050.75 | 173.68 | Sell | No |
Coombe Gary A | 02/27/2025 | 35,000.00 | 57,050.75 | 78.52 | Buy | No |
Coombe Gary A | 02/24/2025 | 18,000.00 | 22,050.75 | 171.66 | Sell | No |
Janzaruk Matthew W. | 02/04/2025 | 4,460.30 | 2,733.73 | 167.96 | Sell | No |
Pritchard Marc S. | 01/22/2025 | 90,450.00 | 172,814.35 | 163.84 | Sell | No |
Pritchard Marc S. | 01/22/2025 | 90,450.00 | 263,264.35 | 85.13 | Buy | No |
Moeller Jon R | 12/18/2024 | 138.82 | 269,532.22 | 169.79 | Sell | No |
Jejurikar Shailesh | 12/18/2024 | 46.27 | 9,914.36 | 169.79 | Sell | No |
Moeller Jon R | 12/18/2024 | 195.16 | 268,352.84 | 169.79 | Sell | No |
Moeller Jon R | 12/18/2024 | 984.22 | 268,548.00 | 169.79 | Sell | No |
Janzaruk Matthew W. | 12/18/2024 | 5.03 | 719.73 | 169.79 | Sell | No |
Davis Jennifer L. | 12/18/2024 | 46.27 | 52,917.70 | 169.79 | Sell | No |
Pritchard Marc S. | 12/18/2024 | 77.46 | 172,814.35 | 169.79 | Sell | No |
Purushothaman Balaji | 12/18/2024 | 31.18 | 11,595.43 | 169.79 | Sell | No |
Date | Name | Dividend | *yield | Currency |
---|---|---|---|---|
2024 | Procter & Gamble Co. | 3.83 | 2.32 | USD |
2023 | Procter & Gamble Co. | 3.68 | 2.43 | USD |
2022 | Procter & Gamble Co. | 3.52 | 2.45 | USD |
2021 | Procter & Gamble Co. | 3.24 | 2.40 | USD |
2020 | Procter & Gamble Co. | 3.03 | 2.53 | USD |
2019 | Procter & Gamble Co. | 2.90 | 2.64 | USD |
2018 | Procter & Gamble Co. | 2.79 | 3.57 | USD |
2017 | Procter & Gamble Co. | 2.70 | 3.10 | USD |
2016 | Procter & Gamble Co. | 2.66 | 3.14 | USD |
2015 | Procter & Gamble Co. | 2.59 | 3.32 | USD |
2014 | Procter & Gamble Co. | 2.45 | 3.12 | USD |
2013 | Procter & Gamble Co. | 2.29 | 2.97 | USD |
2012 | Procter & Gamble Co. | 2.14 | 3.49 | USD |
2011 | Procter & Gamble Co. | 1.97 | 3.10 | USD |
2010 | Procter & Gamble Co. | 1.80 | 3.00 | USD |
2009 | Procter & Gamble Co. | 1.64 | 3.21 | USD |
2008 | Procter & Gamble Co. | 1.45 | 2.38 | USD |
2007 | Procter & Gamble Co. | 1.28 | 2.09 | USD |
2006 | Procter & Gamble Co. | 1.15 | 2.07 | USD |
2005 | Procter & Gamble Co. | 1.03 | 1.86 | USD |
2004 | Procter & Gamble Co. | 0.93 | 1.72 | USD |
2003 | Procter & Gamble Co. | 0.82 | 1.84 | USD |
2002 | Procter & Gamble Co. | 0.76 | 1.70 | USD |
2001 | Procter & Gamble Co. | 0.70 | 2.19 | USD |
2000 | Procter & Gamble Co. | 0.64 | 2.26 | USD |
1999 | Procter & Gamble Co. | 0.57 | 1.29 | USD |
Event | Estimate | Info | Date |
---|---|---|---|
Earnings Report | 1.421 USD | Q4 2025 Earnings Release | 07/29/2025 |
Earnings Report | 1.943 USD | Q1 2026 Earnings Release | 10/15/2025 |
Earnings Report | 1.960 USD | Q2 2026 Earnings Release | 01/28/2026 |
Earnings Report | 1.587 USD | Q3 2026 Earnings Release | 04/17/2026 |
Earnings Report | 1.504 USD | Q4 2026 Earnings Release | 08/04/2026 |
Event | Actual EPS | Info | Date |
---|---|---|---|
Earnings Report | 1.540 USD | Q3 2025 Earnings Release | 04/24/2025 |
Earnings Report | 1.880 USD | Q2 2025 Earnings Release | 01/22/2025 |
Earnings Report | 1.610 USD | Q1 2025 Earnings Release | 10/18/2024 |
Annual General Meeting | 6.020 USD | Annual General Meeting | 10/08/2024 |
Earnings Report | 1.270 USD | Q4 2024 Earnings Release | 07/30/2024 |
Earnings Report | 1.520 USD | Q3 2024 Earnings Release | 04/19/2024 |
Earnings Report | 1.400 USD | Q2 2024 Earnings Release | 01/23/2024 |
Earnings Report | 1.830 USD | Q1 2024 Earnings Release | 10/18/2023 |
Annual General Meeting | 5.900 USD | Annual General Meeting | 10/10/2023 |
Earnings Report | 1.370 USD | Q4 2023 Earnings Release | 07/28/2023 |
Earnings Report | 1.370 USD | Q3 2023 Earnings Release | 04/21/2023 |
Earnings Report | 1.590 USD | Q2 2023 Earnings Release | 01/19/2023 |
Earnings Report | 1.570 USD | Q1 2023 Earnings Release | 10/19/2022 |
Annual General Meeting | 5.810 USD | Annual General Meeting | 10/11/2022 |
Earnings Report | 1.210 USD | Q4 2022 Earnings Release | 07/29/2022 |
Earnings Report | 1.330 USD | Q3 2022 Earnings Release | 04/20/2022 |
Earnings Report | 1.660 USD | Q2 2022 Earnings Release | 01/19/2022 |
Name | Job |
---|---|
Jon R. Moeller | Chairman, President & Chief Executive Officer |
Matthew W. Janzaruk | Chief Accounting Officer & Senior Vice President |
Kirti Singh | Chief Analytics, Insights & Media Officer |
Marc S. Pritchard | Chief Brand Officer |
Damon Jones | Chief Communications Officer |
Philip J. Duncan | Chief Design Officer |
Kristine Decker | Chief Equality & Inclusion Officer |
Ken K. Patel | Chief Ethics & Compliance Officer |
R. Alexandra Keith | Chief Executive Officer-Beauty |
Jennifer L. Davis | Chief Executive Officer-Health Care |
Andre Schulten | Chief Financial Officer |
Balaji Purushothaman | Chief Human Resources Officer |
Seth Cohen | Chief Information Officer |
Shailesh G. Jejurikar | Chief Operating Officer |
Luc Reynaert | Chief Product Supply Officer |
Victor Aguilar | Chief Research, Development & Innovation Officer |
Mindy Sherwood | Chief Sales Officer & President-Global Walmart |
Virginie Helias | Chief Sustainability Officer |
Joe Stegbauer | General Counsel, SVP-Corporate & Global Business |
Brett M. Biggs | Independent Director |
Bertrand-Marc Allen | Independent Director |
Sheila A. Bonini | Independent Director |
Ashley A. McEvoy | Independent Director |
Christine M. McCarthy | Independent Director |
Rajesh Subramaniam | Independent Director |
Terry J. Lundgren | Independent Director |
Christopher J. Kempczinski | Independent Director |
Amy L. Chang | Independent Director |
Patricia Ann Woertz | Independent Director |
Debra L. Lee | Independent Director |
Robert Jones Portman | Independent Director |
Craig Arnold | Independent Director |
John T. Chevalier | Investor Relations Contact |
Joseph Jimenez | Lead Independent Director |
Monica J. Turner | President-North America |
Susan Street Whaley | Secretary & Chief Legal Officer |
Namrata P Patel | Senior Vice President-Product Supply |